In this case study, IQVIA used AI and Machine Learning (ML) to correctly identify more eligible patients and precisely targeted HCPs for our client's biologic treatment.

IQVIA’s accuracy in identifying patients and physicians—via our Dynamic HCP Profiling and Targeting solution—accelerated our client’s commercial success, dramatically improving the switch rate to their specialty drug treatment. In addition, precision HCP alerts enabled our client's sales team to focus their efforts on the right physicians at the right time, raising sales force effectiveness.

Documented Success:

• Twice as many potential patients identified per month with IQVIA's targeting over previous employed methods
• 20% increase in patients transitioning to new drug treatments than previously obtained
• 5x greater rate of treatment transition for IQVIA AIML-identified patients’ vs previous methods
• A dramatic improvement in sales force efficiency and effectiveness as reported by the client